On December 15, we removed a post from view as a result of a law that some have misused to have content removed from the web. Today, we have reinstated that post. Here’s what the post about, if you’re curious:
Following an investigation, a genetics journal has pulled six cancer papers published this year for plagiarizing from other sources. According to an excerpt from the retraction notice in Genetics and Molecular Research, the journal has “strong reason to believe that the peer review process was [a] failure,” and has alerted the authors’ institutions. The notice … Continue reading Journal cleans the house by retracting 6 cancer papers for plagiarism
Researchers have retracted a paper from a plant journal after a probe found problems with several figures. According to the new retraction notice in The Plant Cell, some figures in the paper were manipulated, as well as “inappropriately duplicated and reused from a previous publication.” The authors assert that they believe the conclusions remain valid. … Continue reading Journal issues three notices for plant biologist, two citing manipulation
A scientist in Germany has lost two papers that were collectively cited more than 500 times, after an investigation at her former university found her guilty of scientific misconduct. The probe into Tina Wenz by the University of Cologne in Germany, her former employer, recommended that six of her papers — which have induced some chatter on … Continue reading Researchers retract two well-cited papers for misconduct
Longtime Retraction Watch readers may recall that in 2013, we were forced to temporarily remove ten posts following a false — and frankly ridiculous — copyright infringement claim. Well, it’s happened again. On Wednesday, our host, Bluehost, forwarded us another false copyright claim — aka a Digital Millennium Copyright Act (DMCA) takedown notice — by someone … Continue reading We’ve temporarily removed a Retraction Watch post. Here’s why. (Hint: A bad law.)
Science has retracted a high-profile immunology paper after a probe concluded the corresponding author had committed misconduct. The paper — which initially caught media attention for suggesting a protein could help boost the immune system’s ability to fight off tumors — has been under a cloud of suspicion since last year, when the journal tagged … Continue reading High-profile Science paper retracted for misconduct
Not again. That’s the sound of learning that a third scientist you worked with committed misconduct. In the last two years, we reported on two retractions for neuroscientist Stanley Rapoport, the result of misconduct by two different first authors. We’ve since discovered more retractions resulting from those cases — and a new retraction stemming from … Continue reading More co-author misconduct raises NIH neuroscientist’s retraction count to 8
The week at Retraction Watch featured the story of a graduate student who fought back after being caught in the middle of a fraud case, and the retraction of a hotly debated paper from Nature Cell Biology. Here’s what was happening elsewhere:
A new letter signed by 20 researchers is casting additional doubts on the validity of a potentially invaluable lab tool — and alleges the lab that produced the initial results turned them away when they tried to replicate its findings in mammalian cells. In a letter published this week in Protein & Cell, the researchers … Continue reading More questions arise over gene-editing tool
Two former researchers at Duke University at the center of a lawsuit by a whistleblower to recoup millions in federal funding have lost yet another paper. This is hardly the first retraction for Erin Potts-Kant, who used to work in the pulmonary lab of now-retired William Michael Foster. Earlier this year, a lawsuit filed by a … Continue reading Former Duke researcher at center of lawsuit lodges 16th retraction